<SEC-DOCUMENT>0001193125-25-132885.txt : 20250602
<SEC-HEADER>0001193125-25-132885.hdr.sgml : 20250602
<ACCEPTANCE-DATETIME>20250602092036
ACCESSION NUMBER:		0001193125-25-132885
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250602
DATE AS OF CHANGE:		20250602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOGEN INC.
		CENTRAL INDEX KEY:			0000875045
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				330112644
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19311
		FILM NUMBER:		251013304

	BUSINESS ADDRESS:	
		STREET 1:		225 BINNEY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		7814642000

	MAIL ADDRESS:	
		STREET 1:		225 BINNEY STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOGEN IDEC INC.
		DATE OF NAME CHANGE:	20070427

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOGEN IDEC INC
		DATE OF NAME CHANGE:	20031112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDEC PHARMACEUTICALS CORP / DE
		DATE OF NAME CHANGE:	19970530
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d944881ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Rule <FONT
STYLE="white-space:nowrap">14a-101)</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other
than the Registrant&#8194;&#9744; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>BIOGEN INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
Registrant as Specified In Its Charter) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and <FONT
STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Fellow Stockholders, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ahead of the annual meeting of Biogen Inc. (&#147;Biogen&#148; or the &#147;Company&#148;) on June&nbsp;17, 2025, the Board of Directors (the
&#147;Board&#148;) and Compensation and Management Development Committee (the &#147;CMDC&#148;) want to express our appreciation for our stockholders&#146; consistent support of the Company over many years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has provided oversight of our long-term strategy to create sustainable stockholder value, while the CMDC has continuously improved our compensation
program to align with Company performance and stockholder value. Our executive compensation program is designed to attract and retain the talented and experienced management team required to achieve our goals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Biogen&#146;s Ongoing Transformation Focused on Delivering Long-Term Stockholder Value </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We embarked on a multi-year transformational journey in 2023 to achieve our goal of long-term sustainable growth under the leadership of our Chief Executive
Officer (&#147;CEO&#148;), Chris Viehbacher, who joined us in November 2022. Biogen&#146;s vision and actions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Instituting a portfolio transition that shifts focus from legacy products to growth areas. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reducing and redeploying the company cost base. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Focusing the Research and Development portfolio on value creating programs; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Seeking and executing on external growth opportunities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These actions create a foundation for future growth and we look forward to key pipeline readouts that begin in 2026. We believe our executive compensation
philosophy properly reflects this context, aligning total compensation with long term value creation and Total Shareholder Return (&#147;TSR&#148;), while also recognizing the achievement of near-term milestones with the Short-Term Incentive
(&#147;STI&#148;) program design. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2024, the Company achieved key milestones including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Executed on four new product launches that we believe align with our strongest potential growth drivers.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Further developed our potentially transformative pipeline through internal development efforts as well as
external strategic transactions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Exercised strong financial discipline to reduce and redeploy our cost base, expecting to deliver gross operating
expense savings of approximately $1&nbsp;billion by the end of 2025. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While these achievements demonstrate significant progress in the
second year of this transformation, our stock performance reflects our current stage in this transition. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>The CMDC&#146;s Approach to Compensation Has Resulted in Rigorous Pre-defined Goals to Reward
Short- and Long-Term Performance</I></B><B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CMDC remains committed to our
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> philosophy and the belief that our executive compensation outcomes should align with stockholders&#146; expectations and returns. This philosophy is
reflected in our 2024 executive compensation program design, underpinned by strong governance. Our incentive goals are set in advance every year and are designed to align near- and long-term performance expectations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As in prior years, the CMDC set Biogen&#146;s 2024 executive compensation incentive program targets with discipline and rigor. Short- and long-term financial
goals were set in line with guidance provided to the market. The CMDC also set pipeline milestones and certain corporate responsibility goals to represent Biogen&#146;s culture and commitment to patients. All these elements are critical to near- and
long-term value creation. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Biogen has exceeded analyst EPS expectations in three of the last four fiscal years (2024, 2022 and 2021,
respectively). The 2024 STI achievement of the total compensation is aligned with such financial management performance and demonstrates alignment of the goals to drive performance beyond<I> </I>analysts&#146; expectations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Biogen&#146;s 2024 performance included four product launches we believe will contribute to near- and long-term
sustainable growth, and that delivered $547M in incremental revenue. Our continued pipeline development included the acquisition of Human Immunology Biosciences, Inc., and its drug candidate felzartamab with potential across multiple rare immunology
indications. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The 2024 STI payout recognized achievement of these positive milestones, disciplined execution, cost reductions
and moving Biogen forward toward our multi-year strategic goals. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total compensation for our CEO and executives declined meaningfully in 2024 as the result of the Long-Term
Incentive (&#147;LTI&#148;) program design. As outlined in our proxy filing, 80% of our CEO&#146;s pay and 70% of our other Named Executive Officers (&#147;NEOs&#148;) pay is comprised of stock-based compensation. The PSU award which vested in 2024
had a $0 payout.<B> </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As of December&nbsp;31, 2024, our pay programs have resulted in a CEO total realizable compensation reduction of
66% from the awarded compensation, as illustrated below, demonstrating that our programs are aligned with stockholder experience and our total compensation
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> design is working as intended. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g944881dsp004.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beyond these realizable pay consequences, Biogen&#146;s executive stock ownership guidelines require our NEOs to maintain a
minimum of three times their base salaries, and our CEO to maintain a minimum of six times his base salary. Our stock performance has reduced the value of our executives&#146; stock holdings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to Company goals, our executives are held to rigorous individual performance goals. Goal achievement is measured at the conclusion of the year
based on quantitative and qualitative performance metrics established for the <FONT STYLE="white-space:nowrap">pre-defined</FONT> goals. The CMDC believes that individual performance goals further drive direct accountability of each executive&#146;s
remit and contribution to Biogen&#146;s collective achievements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our CEO&#146;s goals are approved by the Board at the beginning of each year. The CMDC
remains committed to setting robust targets to drive the creation of long-term value for Biogen stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Pay Benchmarking Practices
Appropriately Incentivizes and Rewards Executives </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pay practices for our executives, including our CEO, are benchmarked against our executive
compensation peer group, comprised of 15 companies within the biotechnology/pharmaceutical sector. This peer group has remained largely constant over the last three years, apart from acquisition activity within the group, and is reflective of
Biogen&#146;s profile in terms of size, maturity, global scale, and complexity. Relative to this peer group, Biogen is at median on revenue and 35<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> percentile on market cap indicating reasonable
alignment and consistency with market practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Most importantly, this group reflects the executive talent pool from which Biogen attracts and retains
talent. Our executive hiring has been directly sourced from many of the biopharmaceutical organizations within this group, and therefore, we must be competitive in compensation practices by benchmarking against this group. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Biogen&#146;s Commitment to Stockholder Responsiveness is Evidenced in Pay Design </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reflecting the value the CMDC and Board place on stockholder feedback, over the last several years, independent Directors have consistently engaged with
stockholders to understand their perspectives and gather feedback on our executive compensation programs. In response to feedback received, the CMDC made changes to our executive LTI program in 2024 including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Increased the weighting of PSUs in the LTI mix from 50% to 60%, while also aligning the benchmark from 55<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> to 50<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> percentile for relative TSR consistent with most of our peers. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Added an EPS compound annual growth rate (&#147;CAGR&#148;) metric into the PSU measurement to incorporate an
objective operating metric which management is incentivized to achieve; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Introduced an expanded relative TSR peer group based on a broader biotech index. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not disclose our forward-looking EPS CAGR targets, which is consistent with industry practice, since such disclosure could be interpreted as premature
guidance and potentially competitively harmful. We will continue to disclose performance achievement at the end of the <FONT STYLE="white-space:nowrap">3-year</FONT> performance period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2024, stockholders recognized the alignment of our executive compensation program with Company performance and the creation of long-term stockholder value
by overwhelmingly supporting our Say on Pay proposal, as evidenced by the over 95% vote in favor of our proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will continue to solicit feedback
regarding our executive compensation programs to ensure strong stockholder alignment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conclusion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CMDC is intentional in its design of Biogen&#146;s compensation programs, enabling the Company to attract and retain the talent required to drive
sustainable growth, properly reward near term milestones and provide total compensation that aligns with shareholder value. An important part of that design is setting rigorous goals that align with such objectives and follow a well-defined
governance process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The executive compensation program administered for 2024 remains consistent with our compensation philosophies and was informed by
feedback from our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We appreciate your continued support and request stockholders to vote in line with all Board recommendations including
voting &#147;FOR&#148; the Say-on-Pay proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thank you, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CMDC on behalf of the Board of Directors </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g944881dsp004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g944881dsp004.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#-U+_ )</
M^PE:_P#L] &E0!F:A_K=*_[":_\ I'>T := !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 9NI?\ +A_V$K7_ -GH TJ ,S4/];I7_837
M_P!([V@#3H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M'_0@_'__ ,)7X=?_ #U: #_A]7^RQ_T(/Q__ /"5^'7_ ,]6@ _X?5_LL?\
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MG@MKB18U<I%(P", ?J?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M&;J7_+A_V$K7_P!GH TJ ,S4/];I7_837_TCO: -.@ H * "@ H * /+OCA_
MR17XO_\ 9+OB!_ZB>K5[?#7_ "4>0?\ 8RP/_J52/'XA_P"1!GG_ &+\;_ZC
M5#^<BOZY/Y8"@ H * "@#^BC]GW_ )(;\)/^R>^%/_3/:5_)/%/_ "4N??\
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MA*U_]GH TJ ,S4/];I7_ &$U_P#2.]H TZ "@ H * "@ H \N^.'_)%?B_\
M]DN^('_J)ZM7M\-?\E'D'_8RP/\ ZE4CQ^(?^1!GG_8OQO\ ZC5#^<BOZY/Y
M8"@ H * "@#^BC]GW_DAOPD_[)[X4_\ 3/:5_)/%/_)2Y]_V'XK_ -/3/ZEX
M;_Y)[)/^P'"_^F8'L%>">T% !0 4 % 'Y ?\%J_^36/ /_9?_"O_ *KKXJT
M?K_0 4 % "-G:=O#8.W/.#CC]:RK*HZ-546HUG"2@WLI\KY6_)2L.-DU?9-7
M7EU/R>T/P/\ %BWL_'FF6?@.!OB!?>#[A/B3XOTSX1?$KP'JVL7UOXY\)7>L
MZ7K_ (TO_&/_  C_ .TK=>(O"L?B@Z9=^'XK6XT&UMVTN&>T.K-"=:/L5D^
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M_P $Q_\ LO\ <?\ JQ?@!0!^O] !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 9NI?\N'_82M?_ &>@#2H S-0_UNE?]A-?_2.]H TZ "@ H * "@ H
M \N^.'_)%?B__P!DN^('_J)ZM7M\-?\ )1Y!_P!C+ _^I5(\?B'_ )$&>?\
M8OQO_J-4/YR*_KD_E@* "@ H * /Z*/V??\ DAOPD_[)[X4_],]I7\D\4_\
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M@H * "@ H _(#_@M7_R:QX!_[+_X5_\ 5=?%6@#]?Z "@ H * "@ H * "@
MH * /R _X*._\G3_ /!,?_LO]Q_ZL7X 4 ?K_0 4 % !0 4 % !0 4 % !0
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M]EC_ *$'X_\ _A*_#K_YZM !_P /J_V6/^A!^/\ _P"$K\.O_GJT '_#ZO\
M98_Z$'X__P#A*_#K_P">K0 ?\/J_V6/^A!^/_P#X2OPZ_P#GJT '_#ZO]EC_
M *$'X_\ _A*_#K_YZM !_P /J_V6/^A!^/\ _P"$K\.O_GJT '_#ZO\ 98_Z
M$'X__P#A*_#K_P">K0 ?\/J_V6/^A!^/_P#X2OPZ_P#GJT '_#ZO]EC_ *$'
MX_\ _A*_#K_YZM 'R!\</VU?A9^V#^U/^P)_PK/0/B!H7_"NOC_X?_MO_A.M
M*\.Z9]J_X2WXB_"+^S?[+_L#Q5K7G>5_PC%_Y_G_ &;;YUOY?F;G\H _H^H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@#-U+_ )</^PE:_P#L] &E
M0!F:A_K=*_[":_\ I'>T := !0 4 % !0 4 >7?'#_DBOQ?_ .R7?$#_ -1/
M5J]OAK_DH\@_[&6!_P#4JD>/Q#_R(,\_[%^-_P#4:H?SD5_7)_+ 4 % !0 4
M ?T4?L^_\D-^$G_9/?"G_IGM*_DGBG_DI<^_[#\5_P"GIG]2\-_\D]DG_8#A
M?_3,#V"O!/:"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MVNEV/RF_X6)\0/\ H>?&/_A3:U_\FU^Y?V/E'_0JP?\ X34?_D#\8_MG./\
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M'&[_ /3)=5^L^$G_ "-\T_[ U_Z>@?F7BE_R)\O_ .PQ?^F*I^15?O9^&A0
M4 % 'MW[-O\ R7GX4?\ 8Z:/_P"CJ^9XR_Y);//^P6I^A]+P=_R4V3?]?_\
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MO^^)?_CU'_$?>,?^A;DW_A/C?_GB']E8?^>I]\?_ ) /[?O/^>5M_P!\2_\
MQZC_ (C[QC_T+<F_\)\;_P#/$/[*P_\ /4^^/_R ?V_>?\\K;_OB7_X]1_Q'
MWC'_ *%N3?\ A/C?_GB']E8?^>I]\?\ Y _I/_9SD:7X"_!V5L!I/AQX1D;
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M%2BVDI*Y*485IX:4E&M27-*%]5'GG34EWC[2G4AS*\>>G.-^:,DN^K,84 %
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MUJR+"@ H * "@ H * "@ H * "@ H * "@ H * "@ H S=2_Y</^PE:_^ST
M:5 &9J'^MTK_ +":_P#I'>T := !0 4 % !0 4 ?F9\1/V.?C1XS^)7Q ^.%
MC\4;?2?'"_%KX=^+OAGX)BO8/^$"N/"7PQ6QLM"MO&&IR^#)]<T[6I]/U'QO
MOATJX>T5]>VR>>LDI%9/-95_8]6K!XN<<=F6)S.G+6"HYG&IE^(C@;.FZE99
M/3P=&*Q#C3=:C:/L[1K.LT4,PAF&&A?#4'E%#!8.I'^)]:P\O[3ISQ,&W%48
MYVH5E*D_;^QIQDV^6-!?"6M>'OB=#8?%O0Y?@?X_\6/J@^.5CX9MM.M/'"'X
M':9KGQ?T_P 5WVIR^&+GX:V-M-;Z[?V.F:O:7&E^+OB5?1BQ^U6>F7%HDVF/
MGE]2M#+>'XQQ'U>OA8<(2EF$[6PZRS$4I4,OJ<U+VN'EE[JXARY<MQRI1IJG
MC,3B:7LL6;9CKF&<3J4XXNE7EG2_L^F[+&3QN18K"5,;2FJOLJT*].-/"U%5
MQ^61Q$J\GA,/@\3)T(?9'[/7PN\?^/M:^'?BO6/#*::/A;^T#XT\=>-_&OB?
M5O$MY-\8Y_%7PAF\-+XL\+VNO?"GP5*);/4KW2]-EA;PYH=BHT662S:4IA_6
MPTJ.$CA,5R_5J$LCSO*J.$C9U</6Q6>X+,%BG)UJLO88V=+'5U*<XUH^U@HT
M(T)PY?)J1=2GF6!3=>M4Q?#V+^L2YE3]C@,/7H/ V=.%JN#H1P\;0C.,I5)*
MK6=:-23YSQ#^QKX\\#Z?\9]9N]$LOB+H=CHO[1GB;P4\7Q&^+_B7Q%K%Y\6M
M+UYH_#6F?!**_P!)\*Z'J(_M>>UOM0LM2NY]3^S6TT<4-VV^/Y[F>#X?AA)*
M4,5ALORW*(U:?-6FZ&&S/!XAXOZQ4I5ZV"I4XX:CB70PV%Q/LL12E44*])/#
MUOHJ$J>(XDP^,C*V%Q&:0S2K&I*%%4:U/!U*,J2A&U/%SG*=6A1K8BKAU'"5
MY8:;BOWD><^"?@#]H/QIHNI:7X>T^ZL]0TWQC\/=<\?^/?%'C/QYX0/Q6T"#
MX?ZKX3L?"6B>*)O@-X3UCPCJ_@R&#0VN?["\-)'=J[6DNKM</<R2>QF%&.*H
MU9MTX4*]?/Z52G&3YJV,S"C@9+/4X2YL3AZKC4PLL)56"H5724J=)48)+Y_!
M3>&A0IP@WB*6791'#N4%;"83+\=BJO\ 8]6,XRA0JU)5ZV(IXE3QV(P_.W-M
MSIL]?\,_L6?%+2/"'P\\(76O^#5MU_9@^)W[.7Q!U"TU?7_MNBGQAK,_B#1_
M%7A$R:"/^$BV7B6MK<VFH2:2PCFEE2:5D$<G+F%L;A<_PJM3CFF7\+*C)Q34
M<?PYAJE!T:M.+C'ZEBGB*C]K!NI&-*,?J]JK]GZ67U?J.+RW&VE4J9;Q'Q!F
M:@ZDY.I@L\QOM5_M$Y2JQQF'H1C).7M.:O+6L^7VDO:_V2?V>O%OP8F\3:KX
MWL-%M]=U+PYX*\'1:CI_Q7^*?Q6O]9TOP5;7\-M>75Y\1H[6'PQIOGW]RUCH
M.E63164=S)$;J50BIZ.(QL:^'Q*BI4I8_'ULPJ47:I[*I4I4Z7OXN=Z^,KN%
M.,*F(J1I<U.G13A*2<EY5#!O#3P%+GC6I97@G@Z=7E5'GBZJJ/V>$I_N,)27
M)&7L82J)5IU73=.#M/[4KS3O"@ H * "@ H * "@ H Y3QU!XINO!7BRU\#/
MID/C*Z\.:S;>%9=9N+BTTF#Q!/I]Q%I,^I7-I:W,T-E%?/"\C16\SA4.U&.!
M7#F6'K8O XG"X>HJ-3$P]E[1W_=PJ-0JSC9.\X4G.5-:)S44VDVUV9?5PU#'
M82MBX2J8:A5A4J0BDW.,'S>SM)I6FTHMO9-NSM9_D%XZ_8M^*?P-^%/BB]\.
M^+M;^+VG:Q\!;+X?>./#EY:F\UK2?$6C^,M#\3^&M9\ :?X2\)0WFIZ5I.K:
MCXSOWN=075=1@2Y6X%EJ[(^GS^IB<7"CB?J^%4J&#_MKAS%Y=BY6C5P<LKQ$
M<&JF*4*=6A0HPRNGA:;J4L-7BI8:%.I1E3M5I\.&HUL11AB,8X5L>L#Q-''8
M6+_V?&1SC+L5B,30HRG*E5K5L5FG*E3JU\+&<:]3V6(PLYN_AWB'3OBKJ7V#
M?\,?'%I.E_\ &;_A-?BZ+KXB7&F?'1/&_A?P%:Z[X?L]7LOV=WUG1Y-6T_2U
MT?[(OPO\-6TTNBQOI'B&UD@GCN,I>R5)1>"<L&LNE063N37UQ4\^Q./;B_:5
M55]MC*L\;35?'9=4I4ZU1SHXC!55'#[X:4Z,H2I8OEQM/,\LKT<PLG'+G2R;
M$X*FIQJ4Z:IQPM#V5&=2%''TYU'RUO9XJ,:M7[QMOV7?&'Q1^''[0KWNG:?\
M*7_:'^%_P0L?"/ARZO\ 4;[7_A_>>!_ UA97?AGQ;/#86\D=M#JMK!9NUI//
M+);B5Y$CF_=5T9E3GAYUZ,,7',<5A.,,3GZK4ZD\/2QE)SRF<(>VHWJ4*LYX
M'$6J48SCAYRI5J,ZEM./**E.$\GK+#/"8'"<+/(/8RC[6=&<L3GR=>G2K*"G
M36%S+#3@JWLJLY0G2JPARJ3^?/BK\!_BI\,O#_@77(- ;0/&^O?&.XUW5O%O
MA[XD?&SXQ7'A^PL/A)X@\(+>>*/B1XI^'_C+5;:36;2X_LB*.'X?75O'"UG;
M"[M)XHKM.2K5A[582*E+"5<NSV6(H<BI0Q2S'&91*>6QJ0C5J5ZU>GAO;U).
MM@)5:]&=;#UZ4HSI8OHP]*M3PN*JN<95J$\@H4)<W/.DLNJ8ZM#&4J$ZM&AA
M:.&Q&(;C&-/&0ITJTJ>(PU:,X5<)V&@?LZ_'SXJ>%OA/?V.A:3\-/AII=C^S
MWJGAWX:>)_'7C+2==\ P_"7QC!?^(--UG0+?P.O_  GUSKFE6<6I6%[XEN[.
M?3GDC@.GVT[O/#[D*T<+Q#3S3'U/;UJ>8/'N5+DER8?%Y"L(LO5&%3ZM1Q&6
MXJI4IU<31J5WB87@JL:<.1\-6/UC)L;EV&3C*IA,TP$YS4E'%8AYM5Q%/,XU
M9PAB/JV-I1IRCAIT:*I-^WY'+E3[[Q?^QY\7-0M-4ATO5/#=S'X;_:;\9?'K
MP1%IGQ+^(/PTU7Q-I/Q%T_7;;7O#^M>*_"'A]]2\!:UI,VKQ_8[_ $F35DO(
MXIHIQ;)<N*^>PD)X7!Y!2G'VE?*\LS;):L54J0HSPV-Q:QF'Q=XV=6:FY4L5
M@:D%2G2C>->4I*,?5QE2&+QF?5-:5#-ZF1X^$G"%2=/&95@<+EU7#2IR]UT*
MM+"*M0Q4:BK4:]6+]A^X4JGVY\ _AQ-\)?A+X/\  -S::587>B6M])>V6B:S
MXF\0Z5:7NJZK?:Q>066N>,;J?6-5B6YOY1]JOF1Y&W,L,"%88_3QM>G6J452
M;E1PN&PF%IMTJ=']WA,-2PT%&E2O"$(QI*-./-.2@H\\YSYI/SL-2G!XJK4B
MHU<7B<1B9KVLZSYZ]6524IU9J#J59M^TK34*<9593:CK=^PUQG2% !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0!FZE_RX?\ 82M?_9Z -*@#,U#_ %NE
M?]A-?_2.]H TZ "@ H * "@#Y"_:"^.?QC^%'C[X6^$_ _PO\!^,M*^*^OQ>
M#- U;Q%\1]8\*7MKXM72M=UZ[@U'3;'P)K$<.BII.BY2]CN997FG\LVRJOF,
ML"JF+S&IE[C&FXX;%8V$T^:^%P4,.\0Y*RY:W/7Y:5.[C.,;RJ0;L5BG1PF
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MTE"JZ,HP<,/7PU;FDJRBOJ>H * "@ H * "@ H * "@ H * "@ H * "@ H
MS=2_Y</^PE:_^ST :5 &9J'^MTK_ +":_P#I'>T := !0 4 % !0!XE\5?A
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MC.E6J-4<1]?JYAB)THJG&I5J0II^RA"RH.4J:A6E%R]MA;862]FD?<]8%!0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % &;J7_+A_V$K7_P!GH TJ ,S4A(/L
M$L<,LP@OTED2%=\@C%M=1[@N1P&D0?C0 O\ :7_3AJ7_ ("__9T ']I?].&I
M?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= !_:7_3AJ7_ ("_
M_9T ']I?].&I?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= !_
M:7_3AJ7_ ("__9T ']I?].&I?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:
ME_X"_P#V= !_:7_3AJ7_ ("__9T ']I?].&I?^ O_P!G0 ?VE_TX:E_X"_\
MV= !_:7_ $X:E_X"_P#V= !_:7_3AJ7_ ("__9T ']I?].&I?^ O_P!G0 ?V
ME_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= !_:7_3AJ7_ ("__9T ']I?].&I
M?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= !_:7_3AJ7_ ("_
M_9T ']I?].&I?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= !_
M:7_3AJ7_ ("__9T ']I?].&I?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:
ME_X"_P#V= !_:7_3AJ7_ ("__9T ']I?].&I?^ O_P!G0 ?VE_TX:E_X"_\
MV= !_:7_ $X:E_X"_P#V= !_:7_3AJ7_ ("__9T ']I?].&I?^ O_P!G0 ?V
ME_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= !_:7_3AJ7_ ("__9T ']I?].&I
M?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= !_:7_3AJ7_ ("_
M_9T ']I?].&I?^ O_P!G0 ?VE_TX:E_X"_\ V= !_:7_ $X:E_X"_P#V= %:
M>XDNY+*..RODV7T$KO+!LC2./?N);>?44 ;= !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
> !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
